Cardinal Health, Inc. (LON:0HTG)
Market Cap | 29.30B |
Revenue (ttm) | 172.05B |
Net Income (ttm) | 1.21B |
Shares Out | n/a |
EPS (ttm) | 4.94 |
PE Ratio | 24.32 |
Forward PE | 18.47 |
Dividend | 1.58 (0.96%) |
Ex-Dividend Date | Apr 1, 2025 |
Volume | 143 |
Average Volume | 767 |
Open | 165.99 |
Previous Close | 164.23 |
Day's Range | 164.57 - 165.99 |
52-Week Range | 93.46 - 165.99 |
Beta | 0.68 |
RSI | 78.57 |
Earnings Date | Aug 14, 2025 |
About Cardinal Health
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare... [Read more]
Financial Performance
In 2024, Cardinal Health's revenue was $226.83 billion, an increase of 10.66% compared to the previous year's $204.98 billion. Earnings were $852.00 million, an increase of 158.18%.
Financial numbers in USD Financial StatementsNews
CAH CFO on Pharmaceutical Distributor's Outlook
Aaron Alt, CFO at Cardinal Health (CAH), joins Diane King Hall at the NYSE set to discuss the company's financial outlook. He describes the drugmaker's share buyback plans and recent FY25 guidance rai...
Cardinal Health raises FY25 earnings outlook on investor day

Cardinal Health raises annual profit target
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.

Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirmi...

Cardinal Health CEO Jason Hollar sits down with Jim Cramer
Cardinal Health CEO Jason Hollar joins 'Mad Money' host Jim Cramer to talk the healthcare sector, competition in the space, quarterly results, and more.

Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth
BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. CAH, raising the price forecast from $165 to $170.
Cramer's Stop Trading: Cardinal Health
Jim Cramer breaks down why he's keeping an eye on shares of Cardinal Health.

Cramers Stop Trading: Cardinal Health
Jim Cramer breaks down why hes keeping an eye on shares of Cardinal Health.
Citius Oncology enters distribution services agreement with Cardinal Health

Cardinal Health: Specialty Pharmaceutical Growth Glimmers But Risks Lurk
Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more on CAH stock here.

Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system
Kendall DL™ Multi System simplifies patient monitoring, drives efficiencies for providers DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of it...
Cardinal Health, Cencora upgraded at Wells Fargo on industry outlook

Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now
UnitedHealth Group (NYSE:UNH) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high. This decline was driven by a rare first-quarter earnings miss, a Justice Depar...

Best Dividend Aristocrats For June 2025
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 20...
What's Driving the Market Sentiment Around Cardinal Health?
Cardinal Health's (NYSE: CAH) short percent of float has fallen 10.53% since its last report. The company recently reported that it has 5.33 million shares sold short , which is 2.89% of all regular ...

Marjorie Taylor Greene Goes Shopping For Tesla, Netflix, UnitedHealth And More: 19 Stocks The Congresswoman Bought
Rep. Marjorie Taylor Greene (R-Ga.) has been actively buying stocks in 2025 and is back with more than a dozen more trades less than two weeks after her last disclosure. Here's the latest transactions...

63 Top Dividend Growth Stocks For May 2025
I present 63 high-quality dividend growth stocks for investment for May 2025, categorized by yield: High (4%+), Medium (2.5-3.9%), and Low (

Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Rep. Marjorie Taylor Greene (R-Ga.) has been actively buying stocks in 2025, including transactions that may have been perfectly timed during a market dip. Here's the latest transactions made by the c...

Cardinal Health releases new report on the cell and gene therapy industry
Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio , May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizin...
Cardinal Health raises dividend by 1% to $0.5107

Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Comp...

Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals
Henry Schein Inc. (NYSE: HSIC) reported on Monday that its first-quarter adjusted EPS of $1.15, up 4.5% year over year, beat the consensus of $1.11 . Sales were $3.17 billion, missing the consensus o...

Cardinal Health, Northrop Grumman Among 7 Companies To Announce Dividend Increases In First Half Of May
Parker-Hannifin announced its latest payout boost. Check out companies that I expect will announce their annual dividend increases in the first half of May.

Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks
Cardinal Health Inc. (NYSE: CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17 . Sales remained flat at $54.9 billion, missing t...

Cardinal Health Lifts FY25 EPS Outlook, Sees Growth Despite Tariff Risks
Cardinal Health Inc. CAH on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17.